文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
N. Burchardi
发表
A randomised phase II study investigating durvalumab in addition to an anthracycline taxane-based neoadjuvant therapy in early triple negative breast cancer - clinical results and biomarker analysis of GeparNuevo study.
K. Weber, M. Rezai, P. Fasching, 2019, Annals of oncology : official journal of the European Society for Medical Oncology.